top of page


Doctor and patient

We are now open for enrolment.

Schneider Von Gunn Pharmaceuticals has received Human Research Ethics Committee approval to commence the Genesis Trial. The Genesis Trial is a 4 week double-blind randomised placebo-controlled clinical trial to investigate the efficacy of CBD oil for the management of abdominal pain in patience suffering from Irritable Bowel Syndrome (IBS).

Minimum requirements to apply:

  • Must be at least 18 years of age at the time of consent.

  • Meets Rome IV criteria for IBS.

  • The abdominal pain should be present for at least 1 day per week for the last 3 months and the origin of the symptoms should be at least 6 months prior.


For more information or to apply, please fill out the form below.

Genesis Trial Enquiry

Please take a moment to fill out the form.

Thanks for submitting!

bottom of page